MedPath

四川国瑞药业有限责任公司

Ownership
-
Established
2005-12-07
Employees
-
Market Cap
-
Website
http://www.yaoxie.net/yiyao/com/guorui

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

182

NMPA:182

Drug Approvals

Salbutamol Sulfate Injection

Product Name
硫酸沙丁胺醇注射液
Approval Number
国药准字H20253296
Approval Date
Jan 24, 2025
NMPA

Gadopentetate Dimeglumine Injection

Product Name
钆喷酸葡胺注射液
Approval Number
国药准字H20253071
Approval Date
Jan 8, 2025
NMPA

Etomidate Medium and Long Chain Fat Emulsion Injection

Product Name
依托咪酯中/长链脂肪乳注射液
Approval Number
国药准字H20249049
Approval Date
Oct 16, 2024
NMPA

Structural Fat Emulsion Injection(C₆ ~₂₄)

Product Name
结构脂肪乳注射液(C6~24)
Approval Number
国药准字H20243978
Approval Date
Jun 11, 2024
NMPA

Linezolid and Glucose Injection

Product Name
利奈唑胺葡萄糖注射液
Approval Number
国药准字H20243599
Approval Date
Apr 24, 2024
NMPA

Urapidil Hydrochloride Injection

Product Name
盐酸乌拉地尔注射液
Approval Number
国药准字H20243504
Approval Date
Apr 17, 2024
NMPA

Propofol Medium and Long Chain Fat Emulsion Injection

Product Name
丙泊酚中/长链脂肪乳注射液
Approval Number
国药准字H20194010
Approval Date
Mar 22, 2024
NMPA

Propofol Medium and Long Chain Fat Emulsion Injection

Product Name
丙泊酚中/长链脂肪乳注射液
Approval Number
国药准字H20163045
Approval Date
Mar 22, 2024
NMPA

Propofol Medium and Long Chain Fat Emulsion Injection

Product Name
丙泊酚中/长链脂肪乳注射液
Approval Number
国药准字H20143253
Approval Date
Mar 22, 2024
NMPA

Propofol Medium and Long Chain Fat Emulsion Injection

Product Name
丙泊酚中/长链脂肪乳注射液
Approval Number
国药准字H20143252
Approval Date
Mar 22, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 19
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.